Glutaryl-CoA
Appearance
This article needs more citations. (January 2017) |
| Names | |
|---|---|
| IUPAC name
5-[(2-{3-[(2R)-4-{[1,3-Dihydroxy-1,3-dioxo-3-(3′-O-phosphonoadenosin-5′-O-yl)-1λ5,3λ5-diphosphoxan-1-yl]oxy}-3,3-dimethylbutanamido]propanamido}ethyl)sulfanyl]-5-oxopentanoic acid | |
| Systematic IUPAC name
(9R)-1-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5,10,14,19-pentaoxo-2,4,6-trioxa-18-thia-11,15-diaza-3λ5,5λ5-diphosphatricosan-23-oic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| MeSH | Glutaryl-coenzyme+A |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C26H42N7O19P3S | |
| Molar mass | 881.635 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Glutaryl-coenzyme A is an intermediate in the metabolism of lysine and tryptophan.[1]
Clinical Significance
[edit]Deficiency of glutaryl-CoA dehydrogenase causes glutaric acidemia type 1, an autosomal recessive metabolic disorder[2].In this disorder, impaired metabolism of glutaryl-CoA is associated with elevated levels of organic acids, including glutaric acid and 3-hydroxyglutaric acid [3].
See also
[edit]References
[edit]- ↑ Rao KS, Albro M, Dwyer TM, Frerman FE (Dec 2006). "Kinetic mechanism of glutaryl-CoA dehydrogenase". Biochemistry. 45 (51): 15853–61. doi:10.1021/bi0609016. PMID 17176108.
- ↑ Hedlund, Gary L.; Longo, Nicola; Pasquali, Marzia (2006-05-15). "Glutaric acidemia type 1". American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 142C (2): 86–94. doi:10.1002/ajmg.c.30088. ISSN 1552-4868. PMC 2556991. PMID 16602100.
- ↑ Hedlund, Gary L.; Longo, Nicola; Pasquali, Marzia (2006-05-15). "Glutaric acidemia type 1". American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 142C (2): 86–94. doi:10.1002/ajmg.c.30088. ISSN 1552-4868. PMC 2556991. PMID 16602100.
